Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano-curcumin in chronic obstructive pulmonary disease
IRCT20191222045853N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of nanocurcumin in chronic obstructive pulmonary disease (COPD), sponsored by Urmia University of Medical Sciences. Started Jan 2020; status: completed.
02
Drugs
nanocurcumin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20191222045853N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191222045853N1.